8-K: XWELL Reports Q1 2025 Results, Focuses on Accessible Wellness Expansion

XWELL, Inc. reported its first quarter 2025 financial results, highlighting a focus on expanding its wellness offerings and returning to profitability.

Summary

• XWELL, Inc. reported first quarter 2025 revenue of $7.0 million.
• The company is focused on returning to overall profitability.
• Total cost of sales decreased approximately 6% from the first quarter of 2024.
• Total operating expenses decreased approximately 11% from the first quarter of 2024.
• XWELL secured a three-year extension of its Traveler-based Genomic Surveillance Program with the CDC.
• A private placement closed in January 2025, generating gross proceeds of approximately $4 million.
• The company plans to acquire select medical spas in high-demand metropolitan areas.
• XWELL expects to open a new location in New York City's Penn Station in mid-2025.
• As of March 31, 2025, the company had approximately $3.7 million in cash and cash equivalents and $7.3 million in marketable securities.
• Net loss attributable to XWELL for the first quarter ended March 31, 2025, was approximately $4.7 million, compared to approximately $2.5 million for the 2024 first quarter.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While the company reported a net loss, it is focusing on growth initiatives and has secured a significant partnership with the CDC. The decrease in operating expenses is also a positive sign.

Positives

• XWELL secured a three-year extension of its Traveler-based Genomic Surveillance Program with the CDC.
• The company closed a private placement in January 2025, raising approximately $4 million.
• Total cost of sales decreased approximately 6% from the 2024 first quarter.
• Total operating expenses decreased approximately 11% from the 2024 first quarter.
• The company is expanding its footprint into transportation hubs and metropolitan areas.

Negatives

• First quarter 2025 revenue decreased to $7.0 million compared to $8.7 million in the first quarter of 2024.
• Net loss attributable to XWELL for the first quarter ended March 31, 2025, was approximately $4.7 million, compared to approximately $2.5 million for the 2024 first quarter.
• Revenue from the CDC bio-surveillance program in the first quarter of 2025 was lower than anticipated due to timing of the extension.

Risks

• Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.
• The company's future performance is not guaranteed, and actual results may vary materially from expectations.
• Lower than anticipated revenue from the CDC bio-surveillance program in the first quarter of 2025 due to timing of the extension.

Future Outlook

XWELL is focused on expanding its wellness offerings, including acquiring medical spas and opening new locations, with the goal of returning to overall profitability. The company expects revenue from the CDC bio-surveillance program to increase in subsequent quarters.

Management Comments

• XWELL began 2025 with strong momentum, commented Ezra Ernst, Chief Executive Officer of XWELL.
• With our renewed CDC partnership, continued discipline in operations, and a clear growth plan in wellness and beauty, we believe we are expanding what accessible wellness looks like -anchored in science, backed by biosurveillance, and designed for everyday life.
• Our vision is a seamless continuum of care, added Ernst.
• From biometric screenings at the airport to advanced skin and body treatments on Main Street, we believe that we are democratizing access to trusted, science-proven wellness.

Industry Context

XWELL is positioning itself as a leader in accessible wellness, expanding beyond traditional airport spas to include medical spas and other wellness services in high-traffic areas. This strategy aligns with the growing consumer interest in holistic health and wellness solutions.

Comparison to Industry Standards

• It's difficult to directly compare XWELL's results to industry standards without knowing the specific performance metrics of its direct competitors in the airport spa and wellness space.
• Companies like Be Relax and JetSetGo also operate in airport wellness, but their financial details are not always publicly available.
• XWELL's expansion into medical spas puts it in competition with established chains like Massage Envy and smaller regional players, where profitability metrics vary widely based on location and service offerings.
• The success of the CDC partnership is unique to XWELL and provides a revenue stream not typically seen in the broader wellness industry.

Stakeholder Impact

• Shareholders may be concerned about the net loss but encouraged by the growth initiatives.
• Employees may be affected by the expansion and potential acquisitions.
• Customers will benefit from the expanded wellness offerings and locations.
• Suppliers may see increased demand as the company grows.
• Creditors are not directly impacted as the company has no long-term debt.

Next Steps

• The Company intends to host an investor conference call and webcast in the next several weeks to highlight updates on growth initiatives and forthcoming programs.
• The company plans to acquire select medical spas in high-demand metropolitan areas.
• The company expects to open an XWELL location in New York City's Penn Station in mid-2025.
• The company is pursuing plans to open an additional 6 Naples Wax locations across Florida during 2025.

Key Dates

Keywords

XWELL, wellness, financial results, Q1 2025, revenue, CDC, biosurveillance, XpresSpa, private placement, medical spas